153 related articles for article (PubMed ID: 35169860)
1. Methylation‑associated inactivation of JPH3 and its effect on prognosis and cell biological function in HCC.
Huang Y; Yu Z; Zheng M; Yang X; Huang H; Zhao L
Mol Med Rep; 2022 Apr; 25(4):. PubMed ID: 35169860
[TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
Li Z; Zhang H; Yang J; Hao T; Li S
Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
[TBL] [Abstract][Full Text] [Related]
3. The suppressive role and aberrent promoter methylation of BTG3 in the progression of hepatocellular carcinoma.
Lv Z; Zou H; Peng K; Wang J; Ding Y; Li Y; Ren X; Wang F; Chang R; Liang L; Ding Y
PLoS One; 2013; 8(10):e77473. PubMed ID: 24147003
[TBL] [Abstract][Full Text] [Related]
4. Hypomethylation of the hsa-miR-191 locus causes high expression of hsa-mir-191 and promotes the epithelial-to-mesenchymal transition in hepatocellular carcinoma.
He Y; Cui Y; Wang W; Gu J; Guo S; Ma K; Luo X
Neoplasia; 2011 Sep; 13(9):841-53. PubMed ID: 21969817
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma.
Kong LM; Liao CG; Chen L; Yang HS; Zhang SH; Zhang Z; Bian HJ; Xing JL; Chen ZN
J Cell Mol Med; 2011 Jun; 15(6):1415-28. PubMed ID: 20629990
[TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation‑mediated decrease of lncRNA HNF1A‑AS1 contributes to malignant progression of laryngeal squamous cell carcinoma via EMT.
Shi Y; Zhang Q; Xie M; Feng Y; Ma S; Yi C; Wang Z; Li Y; Liu X; Liu H; Yang H; Yan Y; Zhang Y; Ren X; Luo H
Oncol Rep; 2020 Dec; 44(6):2503-2516. PubMed ID: 33125127
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells.
Chan DW; Lee JM; Chan PC; Ng IO
Int J Cancer; 2008 Sep; 123(5):1043-52. PubMed ID: 18553387
[TBL] [Abstract][Full Text] [Related]
8. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter.
Lin Z; Huang W; He Q; Li D; Wang Z; Feng Y; Liu D; Zhang T; Wang Y; Xie M; Ji X; Sun M; Tian D; Xia L
J Exp Clin Cancer Res; 2021 Feb; 40(1):50. PubMed ID: 33522955
[TBL] [Abstract][Full Text] [Related]
9. Low mir-372 expression correlates with poor prognosis and tumor metastasis in hepatocellular carcinoma.
Wu G; Wang Y; Lu X; He H; Liu H; Meng X; Xia S; Zheng K; Liu B
BMC Cancer; 2015 Mar; 15():182. PubMed ID: 25880458
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.
Qiu W; Zhou B; Zou H; Liu X; Chu PG; Lopez R; Shih J; Chung C; Yen Y
Am J Pathol; 2004 Nov; 165(5):1689-99. PubMed ID: 15509538
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
He Y; He X
Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
[TBL] [Abstract][Full Text] [Related]
12. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
[TBL] [Abstract][Full Text] [Related]
13. SOCS3 Methylation Predicts a Poor Prognosis in HBV Infection-Related Hepatocellular Carcinoma.
Zhang X; You Q; Zhang X; Chen X
Int J Mol Sci; 2015 Sep; 16(9):22662-75. PubMed ID: 26393582
[TBL] [Abstract][Full Text] [Related]
14. CDC20 promotes the progression of hepatocellular carcinoma by regulating epithelial‑mesenchymal transition.
Yang G; Wang G; Xiong Y; Sun J; Li W; Tang T; Li J
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33907851
[TBL] [Abstract][Full Text] [Related]
15. Reduced T-cadherin expression and promoter methylation are associated with the development and progression of hepatocellular carcinoma.
Yan Q; Zhang ZF; Chen XP; Gutmann DH; Xiong M; Xiao ZY; Huang ZY
Int J Oncol; 2008 May; 32(5):1057-63. PubMed ID: 18425332
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
[TBL] [Abstract][Full Text] [Related]
17. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
[TBL] [Abstract][Full Text] [Related]
18. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
[TBL] [Abstract][Full Text] [Related]
19. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
20. CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
Zhao R; Wang N; Huang H; Ma W; Yan Q
Liver Int; 2014 Jul; 34(6):e151-60. PubMed ID: 24529164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
